Scarica l'app Stockscreener
39.73
1.51%
-0.61
Dopo l'orario di chiusura:
39.89
0.16
+0.40%
Caredx Inc Borsa (CDNA) Ultime notizie
Form 4 Caredx Inc For: 17 July By Investing.com - Investing.com South Africa
CareDx CEO John Hanna sells $4.46m in company stock - Investing.com
[Form 4] CareDx, Inc. Insider Trading Activity - Stock Titan
CareDx (CDNA) director sells 28,779 shares and exercises options - Stock Titan
H.C. Wainwright reiterates Neutral stock rating on CareDx - Investing.com
H.C. Wainwright reiterates Neutral stock rating on CareDx By Investing.com - Investing.com Canada
CareDx (CDNA) Moves 35.6% Higher: Will This Strength Last? - Yahoo Finance
CareDx rallies after Medicare finalizes transplant testing coverage policy - MSN
CareDx says final Medicare LCD maintains coverage for transplant rejection surveillance tests - Bitget
CareDx sets webcast to discuss second-quarter 2026 results after market close - Bitget
BTIG raises CareDx stock price target to $45 on coverage decision By Investing.com - Investing.com South Africa
Price to earnings forward of CareDx, Inc. – GETTEX:1K9 - TradingView
CareDx Inc. (CDNA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Form 144 | CareDx(CDNA.US) Director Proposes to Sell 3.51 Million in Common Stocks - Moomoo
CareDx (CDNA) Jumps As Naveris Deal Redraws Growth Map - timothysykes.com
Form 144 CAREDX For: 16 July By Investing.com - Investing.com Canada
CDNA (NASDAQ: CDNA) holder John Hanna files notice to sell 118,000 shares - Stock Titan
Planned 28,779-share CDNA (NASDAQ: CDNA) sale follows earlier 10b5-1 trade - Stock Titan
Caredx Inc stock hits 52-week high at 36.4 USD By Investing.com - Investing.com South Africa
CAREDX INC : BTIG RAISES TARGET PRICE TO $45 FROM $28 - Bitget
CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) - MSN
CDNA Maintained by BTIG -- Price Target Raised to $45 - GuruFocus
Why Is CareDx Stock Skyrocketing Thursday? - Benzinga
BTIG raises CareDx stock price target to $45 on coverage decision - Investing.com Canada
Caredx Inc stock hits 52-week high at 36.4 USD - Investing.com
CareDx to report Q2 2026 financial results on July 30 - scanx.trade
CareDx (CDNA) Secures Medicare Coverage for Molecular Testing - GuruFocus
CareDx stock surges 20% on Medicare coverage policy By Investing.com - Investing.com India
CareDx stock surges 20% on Medicare coverage policy - Investing.com
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 - Business Wire
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination - Business Wire
How Caredx Inc. (CDNA) Affects Rotational Strategy Timing - Stock Traders Daily
CareDx (CDNA) Following Reimbursement Progress Is The Stock Starting To Look Fully Valued - Sahm
Price to earnings forward of CareDx, Inc. – LSX:A118WG - TradingView
Frontier tech research, news & data - MLQ.ai
CareDx to Participate in Upcoming Investor Conferences - AOL.com
Form 4 Caredx Inc For: 7 July By Investing.com - Investing.com Nigeria
CareDx (CDNA) director receives 1,746-share quarterly stock grant as compensation - Stock Titan
CareDx (CDNA) exits lab products and acquires Naveris to expand $12B market - Stock Titan
CareDx Completes Naveris Acquisition and Expands Oncology Reach - Yahoo Finance
CareDx: The Transplant Platform Is Becoming A Specialty Diagnostics Compounder (CDNA) - Seeking Alpha
Diagnostic Co.'s Oversight Reforms Deal Gets Final OK - Law360
Form 4 Caredx Inc For: 6 July By Investing.com - Investing.com Nigeria
CareDx (CDNA) CEO has 8,511 shares withheld for RSU tax obligations - Stock Titan
CareDx Leaders’ Audit Reforms Settlement Gets Court Approval (1) - Bloomberg Law News
CareDx Deadline Alert - TMX Newsfile
Enterprise value to EBITDA forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
CareDx Inc (CDNA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CDNACaredx Inc Short Interest - Finviz
CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology - Yahoo Finance
CareDx Inc. (CDNA) Holds Steady Near Resistance as Consolidation ContinuesSystematic Flow - dars.gov.et
CareDx (CDNA) general counsel has 997 shares withheld for tax obligations - Stock Titan
CareDx (CDNA) CCO has shares withheld to cover taxes on RSU vesting - Stock Titan
CareDx (CDNA) CFO & COO reports RSU tax withholding, holds 219,924 shares - Stock Titan
Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division - Clinical Lab Products
(CDNA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology - BioSpace
CareDx Completes Acquisition of Naveris, Extending Leadership in - GuruFocus
CareDx completes acquisition of Naveris - Investing.com
CareDx completes acquisition of Naveris By Investing.com - Investing.com Canada
Eurobio Scientific closes an acquisition - marketscreener.com
Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division - GlobeNewswire
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific - BioSpace
CareDx president and CEO John Hanna sells $1.17m stock By Investing.com - Investing.com South Africa
CareDx completes sale of lab products unit for $171.2M - Investing.com UK
0.61%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):